首页> 外文OA文献 >P389 Efficacy of once a day multi matrix mesalamine formulation, lialda in patients with active mild to moderate ulcerative colitis after inadequate response to the pH-dependent release mesalamine formulation, asacol

【2h】

P389 Efficacy of once a day multi matrix mesalamine formulation, lialda in patients with active mild to moderate ulcerative colitis after inadequate response to the pH-dependent release mesalamine formulation, asacol

机译：P389疗效每日一次Metrix mesalamine配方，Lialda在患者中有活性轻度至中度溃疡性结肠炎的患者不足反应对pH依赖性释放梅纳胺制剂，asacol

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
N Yoshimura; S Okano; M Sako; M Takazoe;
展开▼
作者单位

展开▼
年度 2018
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
专利

1. Combination of Curcumin (an Active Ingredient of Curcuma Longa) and Mesalamine Versus Mesalamine Alone in the Treatment of Mild to Moderate Ulcerative Colitis A Proposal for a Multicenter Prospective Study: Amendment 1 (19.6.2011) [J] . Clinical gastroenterology and hepatology: the official clinical practice journal of the American Gastroenterological Association . 2016,第6期

机译：姜黄素（姜黄素的有效成分）与美沙拉敏与单独使用美沙拉敏的组合治疗轻度至中度溃疡性结肠炎的多中心前瞻性研究建议：修订案1（19.6.2011）
2. Combination of Curcumin (an Active Ingredient of Curcuma Longa) and Mesalamine Versus Mesalamine Alone in the Treatment of Mild to Moderate Ulcerative Colitis A Proposal for a Multicenter Prospective Study: Amendment 1 (19.6.2011) [J] . Clinical gastroenterology and hepatology: the official clinical practice journal of the American Gastroenterological Association . 2016,第6期

机译：姜黄素（莪术活性成分）和梅纳胺与梅立胺的组合单独用于治疗轻度至中度溃疡性结肠炎的多中心前瞻性研究的提案：修订1（19.6.2011）
3. Delayed-release oral mesalamine 4.8 g/day (800-mg tablet) is effective for patients with moderately active ulcerative colitis. [J] . Sandborn WJ, Regula J, Feagan BG, Gastroenterology . 2009,第6期

机译：延迟释放口服美沙拉敏4.8 g /天（800毫克片剂）对中度活动性溃疡性结肠炎患者有效。
4. Efficacy and safety of two pH-dependent-release mesalamine doses in moderately active ulcerative colitis: a multicenter randomized double-blind parallel-group study [O] . Yasuo Suzuki, Mitsuo Iida, Hiroaki Ito, 2016

机译：两种pH依赖性释放美沙拉敏剂量在中度活动性溃疡性结肠炎中的疗效和安全性：多中心随机双盲平行组研究
5. Efficacy and safety of two pH-dependent-release mesalamine doses in moderately active ulcerative colitis: a multicenter, randomized, double-blind, parallel-group study [O] . Yasuo Suzuki, Mitsuo Iida, Hiroaki Ito, 2016

机译：两种pH依赖性乳腺素剂量在适度活性溃疡性结肠炎中的功效和安全性：多中心，随机，双盲，并行群体研究

P389 Efficacy of once a day multi matrix mesalamine formulation, lialda in patients with active mild to moderate ulcerative colitis after inadequate response to the pH-dependent release mesalamine formulation, asacol

著录项

相似文献

相关主题

期刊订阅